Cergutuzumab (Anti-CEACAM5 / CEA / CD66e)
Cergutuzumab (Anti-CEACAM5 / CEA / CD66e) is a humanized monoclonal antibody which targets Carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5) with immunostimulating and antineoplastic activities. MW : 146.48 KD.
Supplier | Selleck Chemicals |
---|---|
Product # | A2841 |
Sku # | A2841-1mg |
Pricing | 1mg, $570.00 |